These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6897455)

  • 41. Early and late results of coronary artery bypass in patients with hyperlipoproteinemia.
    Hanson EC; Levine FH; Adzick NS; Lees RS; Daggett WM; Austen WG; Buckley MJ
    J Thorac Cardiovasc Surg; 1980 Mar; 79(3):372-80. PubMed ID: 6965512
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study of metabolic and clinical effects of polyunsaturated fatty acids omega-3 from "Eicovit" in patients with ischemic heart disease and familial hyperlipoproteinemia].
    Sorokovoĭ KV; Pogozheva AV; Kulakova SN; Lupinovich VL; Karagodina ZV; Levachev MM; Samsonov MA; Vorsanovich EA
    Vopr Pitan; 1998; (2):29-31. PubMed ID: 9680669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of 1,5-dicafleylquinic acid (cynarine) on hypertriglyceridemia in aged patients].
    Mars G; Brambilla G
    Med Welt; 1974 Sep; 25(39):1572-4. PubMed ID: 4427557
    [No Abstract]   [Full Text] [Related]  

  • 45. [Preliminary evaluation of the usefulness of determination of apolipoprotein B. cholesterol and VLDL triglyceride concentrations in the early diagnosis of type IV hyperlipoproteinemia].
    Bobilewicz D; Kotlicka J; Grajnert K
    Pol Tyg Lek; 1981 Mar; 36(9):325-6. PubMed ID: 7267451
    [No Abstract]   [Full Text] [Related]  

  • 46. [Electroretinographic investigations in subjects in chronic exposure to carbon disulphide: III. Cynarex effect on ERG related to blood lipid pattern (author's transl)].
    Palacz O; Czepita D; Wójcicki J
    Klin Oczna; 1981; 83(4-5):223-5. PubMed ID: 6895532
    [No Abstract]   [Full Text] [Related]  

  • 47. [Familial hyperprebetalipoproteinemia].
    Makurat D; Górski J
    Pol Tyg Lek; 1980 Apr; 35(14):501-2. PubMed ID: 7402960
    [No Abstract]   [Full Text] [Related]  

  • 48. First-line therapies for lowering triglyceride levels.
    Raghavan VA
    Am Fam Physician; 2008 Feb; 77(4):416; author reply 417-8. PubMed ID: 18326158
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical effects and tolerance of etofylline clofibrate].
    Ziegler WJ; Metz G; Specker M
    Arzneimittelforschung; 1980; 30(11b):2053-8. PubMed ID: 7194059
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Etofylline clofibrate in the treatment of diabetic dyslipidemia: results of a 6-month period of therapy].
    Rajecová E; Klimes I; Seböková E; Rychnavská E; Pleváková L; Linke-Cvrkalová A; Langrová H
    Vnitr Lek; 1995 Oct; 41(10):677-81. PubMed ID: 8578698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Severe hypertriglyceridemia during the course of treatment with interferon-alpha in a patient with chronic hepatitis C].
    Bory E; García Rico A; Pedro-Botet J; Sola R
    Gastroenterol Hepatol; 1996 Dec; 19(10):542. PubMed ID: 9044758
    [No Abstract]   [Full Text] [Related]  

  • 52. [Gas exchange in the lung in hypertriglyceridemia after myocardial infarct].
    Frank-Piskorska A; Bartnikowska E
    Pol Tyg Lek; 1980 Jul; 35(29):1089-90. PubMed ID: 7433184
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of hypolipidemic treatment on serum markers of vascular inflammation in dyslipidemic men.
    Hernández C; Lecube A; Barberá G; Chacón P; Lima J; Simó R
    Med Sci Monit; 2003 Mar; 9(3):CR114-9. PubMed ID: 12640339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia].
    Tomei R; Rossi L; Carbonieri E; Franceschini L; Cemin C; Ghebremariam-Tesfau K; Zardini P
    Cardiologia; 1993 Dec; 38(12):773-8. PubMed ID: 8200011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical experience with bezafibrate.
    Schubotz R; Schneider J; Hausmann L; Mühlfellner G; Mühlfellner O; Kaffarnik H
    Artery; 1980; 8(6):553-9. PubMed ID: 7259534
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simvastatin now indicated to lower triglycerides.
    Nurse Pract; 1998 Jan; 23(1):99. PubMed ID: 9470204
    [No Abstract]   [Full Text] [Related]  

  • 57. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS; Chait A; Hazzard WR
    J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of etofibrate retard, bezafibrate and procetofen.
    Luley C; Schwartzkopff W; Schilling A; Calder D; Scheffler W
    Artery; 1980; 8(2):128-33. PubMed ID: 7458677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oligo-arthritis and type IV hyperlipoproteinemia.
    Soubrier M; Dubost JJ; Thiéblot P; Ristori JM
    Joint Bone Spine; 2009 Jan; 76(1):95-7. PubMed ID: 19064332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the intravenous fat tolerance test in chronic renal disease.
    Russell GI; Davies TG; Walls J
    Clin Nephrol; 1980 Jun; 13(6):282-6. PubMed ID: 7408247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.